Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Molecular Cancer|November 25, 2011
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell linesRoberta R Alfieri, Maricla Galetti, Stefano Tramonti, et al.Cancer Letters|April 10, 2012
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clonesAndrea Cavazzoni, Mara A Bonelli, Claudia Fumarola, et al.Molecular Cancer Therapeutics|May 28, 2015
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene AlterationsMara A Bonelli, Andrea Cavazzoni, Francesca Saccani, et al.Breast Cancer Research and Treatment|January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cellsMara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.Cancer Chemotherapy and Pharmacology|November 22, 2013
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinibMarcello Tiseo, Massimo Ippolito, Maura Scarlattei, et al.Molecular Cancer|December 14, 2012
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell linesAndrea Cavazzoni, Roberta R Alfieri, Daniele Cretella, et al.Oncotarget|May 28, 2015
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitorElena Galvani, Jing Sun, Leticia G Leon, et al.Pageof 4